Myeloma Minute: Myeloma Drug News


| INNOVATION | Drug News


European Commission Approves a Darzalex (Daratumumab) Drug Combination

The European Commission approved Darzalex® (daratumumab) in combination with bortezomib, thalidomide, and dexamethasone (VTd) for newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplant (ASCT). According to Janssen Pharmaceutical Companies, “This approval is based on results from part one of the phase III CASSIOPEIA (MMY3006) study, published in The Lancet in June 2019 and presented at the 2019 American Society of Clinical Oncology (ASCO) Meeting.”


| INNOVATION | Drug News


FDA Grants Priority Review of Belantamab Mafodotin

The U.S. Food and Drug Administration (FDA) granted a priority review for GlaxoSmithKline’s (GSK) Biologics License Application (BLA). GSK is “seeking approval of belantamab mafodotin (GSK2857916) for the treatment of patients with relapsed or refractory multiple myeloma whose prior therapy included an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody.” This application is based on data “from DREAMM-2 (DRiving Excellence in Approaches to Multiple Myeloma) study, recently published in The Lancet Oncology.”


| EDUCATION | Seminar


| EDUCATION | Workshop


Register Now for the 2020 IMF Patient & Family Seminar in Boca Raton, FL
Register Now for the Regional Community Workshop in Birmingham, Alabama

From March 13-14, 2020, the IMF will host a Patient & Family Seminar at the Boca Raton Marriott (5150 Town Center Circle) in Boca Raton, FL. Choose between two registration packages—either attend Friday’s half-day session and the all-day session Saturday, or attend the Saturday session only. Connect with other patients and caregivers. Together, we can learn, build community, and share our stories.

The IMF will host a Regional Community Workshop at The Westin (2221 Richard Arrington Jr. Blvd North) in Birmingham, Alabama, on Saturday, March 21, 2020. Registration is FREE, but seating is limited. Learn from and meet one-on-one with myeloma experts to get answers to your questions and concerns.

Register Now Button.png

Register Now Button.png

| INSPIRATION | Fundraiser

2nd Annual LA Walk for Myeloma 2020.png

Register Now for the 2nd Annual Walk for Myeloma Miracles in Rancho Cucamonga, CA

Join in the fun and register for the 2nd Annual Walk for Myeloma Miracles at Central Park (11200 Base Line Rd.) in Rancho Cucamonga, California, on Saturday, March 21, 2020. Proceeds from the event will benefit the most promising research initiatives as well as patient support programs of the International Myeloma Foundation. Note: The event is not timed; it's a casual walk. The shortest distance on the trail is 2 miles, but participants can opt to go 5 miles. It is also bicycle-friendly.

Register Now Button.png

| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



Search the Myeloma Matrix 2.0

Join the conversation about myeloma on the Smart Patients Message Board

Clinical Trial Fact Sheets

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

March 7, 2020
Masters Tennis for Myeloma
Villages, FL

March 13-14, 2020
IMF Patient & Family Seminar
Boca Raton, FL

April 25, 2020
12th Annual Miles for Myeloma 5K Run/Walk
Philadelphia, PA

May 8-9, 2020
IMF Patient & Family Seminar
Seattle, WA

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Bristol-Myers Squibb, Genentech, Sanofi-Genzyme, and Takeda Oncology

We also thank individuals like you for your continued support!

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.